Reason for request
Modification du RCP
Modification d’AMM du 02/07/2018 : restriction de l’indication aux patients ayant une tumeur avec expression de PD-L1 ≥ 5% dans le traitement du carcinome urothélial chez les patients inéligibles au cisplatine
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
2vS2CgqMxbg8Sq90
